Search clinical trials for: Regular human insulin
Total 6952 results
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIsrael, Italy, United Kingdom, Denmark, Spain, Singapore, Taiwan, Germany, France, Hong Kong, Brazil
-
SanofiCompletedDiabetes Mellitus, Insulin-DependentUnited States
-
SanofiCompleted
-
Odense University HospitalCompletedType 2 Diabetes MellitusDenmark
-
University Hospital, Strasbourg, FranceTerminatedOxidative Stress | Gestational Diabetes | Treatment | MetforminFrance
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Rabin Medical CenterSanofiTerminated
-
Universidad de GuanajuatoCompleted
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
GeropharmCompletedDiabetes Mellitus, Type 2Russian Federation
-
The Hashemite UniversityCompletedDiabetes Mellitus | Cardiac EventJordan
-
University Hospital TuebingenCompletedObesity | DiabetesGermany
-
Mayo ClinicArizona State UniversityTerminated
-
Göteborg UniversityMedical Research Council; Swedish Cancer FoundationCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Dance Biopharm Inc.CompletedType 1 Diabetes Mellitus
-
Jing LuoThe Leona M. and Harry B. Helmsley Charitable TrustActive, not recruitingDiabetes Mellitus, Type 1 | Type 1 DiabetesTanzania, Bangladesh
-
Zhejiang Provincial People's HospitalNot yet recruitingType2 Diabetes | type1diabetesChina
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
Vanderbilt University Medical CenterWithdrawnObesity | Hyperinsulinemia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Egypt
-
Amphastar Pharmaceuticals, Inc.Completed
-
Fundación Pública Andaluza Progreso y SaludCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1China
-
Halozyme TherapeuticsCompleted
-
Marcus SaemannCompleted
-
Baylor College of MedicineCompletedHyperglycemia | Diabetes MellitusUnited States
-
University of Missouri-ColumbiaRecruitingHealthy | Obesity | Insulin Resistance | Vasodilation | Autonomic DysfunctionUnited States
-
Jinnah Postgraduate Medical CentreCompleted
-
AdociaCompleted
-
HealthPartners InstituteSanofi; International Diabetes Center at Park NicolletCompletedHyperglycemiaUnited States
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Germany, Switzerland
-
Dance Biopharm Inc.WCCT GlobalTerminatedSafety and TolerabilityUnited States
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
University Hospital TuebingenRecruitingCentral Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2DDiabetes Mellitus, Type 2 | PreDiabetes | Central Insulin ResistanceGermany
-
University Hospital TuebingenCompletedObesity | Insulin ResistanceGermany
-
GenesysNovo Nordisk A/SCompletedSepsis | Respiratory Failure | Renal Failure | Surgical Site InfectionUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesBrazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Germany, Finland, France
-
University of Sao Paulo General HospitalCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseBrazil
-
University of SurreyNovo Nordisk A/SCompleted
-
CPEX Pharmaceuticals Inc.Completed
-
Novo Nordisk A/SCompleted